Hormone Therapy: 472 Real Stories

472 stories match hormone therapy. 400 of them mention surgery.

Cancer Stories

Abigail, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV HR-Positive Breast Cancer: Abigail's Patient Story

Patient Info: Abigail Myers, female, Under 40 | Stage IV

Biomarkers: ER-positive, PR-positive, HER2-positive

Metastatic Site: bones, brain

Abigail continued living with Stage IV metastatic breast cancer after about 8 years of multiple treatment lines, including therapy for bone and brain metastases.

Dana-Farber
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Chemotherapy complication: methotrexate absorbed into the bloodstream after spinal injection

Patient Info: Anonymized, Female | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative; Oncotype DX Recurrence Score 20

Metastatic Site: leptomeninges / central nervous system; brain

Five months after leptomeningeal carcinomatosis was recognised, she developed a new 2 cm brain lesion and neurological decline. Her family chose supportive care, and she died 10 days after transfer to inpatient hospice.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Breast cancer that spread to the thymus gland

Patient Info: Anonymized, Female | Stage IV

Biomarkers: Oestrogen receptor-positive; progesterone receptor-positive; HER2-negative

Metastatic Site: thymus

She had a good response after 4 cycles of abemaciclib, anastrozole and goserelin and continued endocrine treatment with surveillance of the opposite breast.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

HER2-positive breast cancer on hemodialysis: partial response to T-DM1 then no metabolically active disease

Patient Info: Anonymized, Female, 60s | Stage II

Biomarkers: Hormone receptor-positive; HER2/neu-positive; E-cadherin-positive; Ki-67 55-60%; luminal B type

As of March 2023, after 12 total cycles of T-DM1 and modified radical mastectomy, PET-CT showed no metabolically active disease, and she continued endocrine therapy and dialysis.

PubMed Central
OutcomeCancer-Free / NED
Renée, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Renée's Patient Story

Patient Info: Renée, Female, Under 40 | Stage II

Biomarkers: Not genetically inherited; breast cancer linked by her team to prior doxorubicin exposure and total-body radiation

As of February 2023, Renée described stable health, working treatments, good bloodwork, and ongoing long-term hormone/anti-cancer therapy; she did not consider herself cancer-free and preferred survivor/thriver language.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Stage IV Breast CancerBreast Cancer

Rare breast cancer subtype that recurred years later in a more aggressive form

Patient Info: Anonymized, Female | Stage IV

Biomarkers: CD117 focally positive in the transformed component; high Ki-67; hormone-receptor status was unknown at the original diagnosis

Metastatic Site: lungs

One year after treatment for the late chest-wall recurrence, CT showed another local recurrence and metastatic nodules in both lungs. She chose to continue treatment elsewhere.

PubMed Central
OutcomeSetback / Progression
Carol, who was diagnosed with Stage I Invasive Lobular CarcinomaBreast Cancer

Stage I Invasive Lobular Carcinoma: Carol's Survivor Story

Patient Info: Carol, Female, 70+ | Stage I

Carol recovered from lumpectomy for stage 1A disease and was doing well on an aromatase inhibitor, with occasional hot flashes.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing / Survivorship
Catriona, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Catriona's Survivor Story

Patient Info: Catriona, Female, 60s | Stage I

Catriona described herself as a breast cancer survivor who had recovered after treatment and was focused on long-term wellbeing and family.

Our Cancer Stories
OutcomeTreatment Completed / Survivorship
Jodi, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Jodi's Patient Story

Patient Info: Jodi | Stage III

Jodi remained on tamoxifen after mastectomy for stage 3 breast cancer and had declined the recommended chemotherapy and radiation therapy.

Our Cancer Stories
OutcomeCare Ongoing
Annette, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

HR-Positive Invasive Ductal Carcinoma: Annette's Patient Story

Patient Info: Annette La Fontaine, Female

Biomarkers: ER-positive; PR-positive; HER2-negative

As of January 2023, Annette was in survivorship after bilateral mastectomy and reconstruction and was taking a daily aromatase inhibitor to reduce recurrence risk while rebuilding body confidence and emotional well-being.

The Patient Story
OutcomeCare Ongoing
Diana, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Diana's Patient Story

Patient Info: Diana, Female, 40s | Stage III

As of 2023, Diana was receiving treatment for Stage III breast cancer after quadrantectomy, chemotherapy, radiation therapy, hormone therapy, unilateral oncological mammoplasty, and lymph-node removal.

Our Cancer Stories
OutcomeCare Ongoing
Lan, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Lan's Patient Story

Patient Info: Lan | Stage II

Lan had completed surgery, chemotherapy, and radiation and remained on hormone therapy, with ongoing concern about treatment effects but growing optimism.

Our Cancer Stories
OutcomeCare Ongoing
Maiv, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Maiv's Patient Story

Patient Info: Maiv | Stage II

Maiv had completed active treatment and remained on hormone therapy at the time of her story.

Our Cancer Stories
OutcomeCare Ongoing
Alicia, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Alicia's Patient Story

Patient Info: Alicia, Female, 50s | Stage II

As of 2023, Alicia had undergone Stage II breast cancer treatment with mastectomy, hormone therapy, and DIEP flap reconstruction, with no treatment side effects described and a focus on recovery and wellbeing.

Our Cancer Stories
OutcomeCare Ongoing
Gayna, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Gayna's Survivor Story

Patient Info: Gayna, Female, 50s | Stage I

Gayna completed treatment for Stage I breast cancer and described optimism, thankfulness, permanent diet/exercise changes, and plans to stay well and enjoy life.

Our Cancer Stories
OutcomeSurvivorship / Completed Treatment
Lesley, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Lesley's Patient Story

Patient Info: Lesley | Stage II

Lesley had completed her main cancer treatment and remained on hormone therapy while continuing to recover and rebuild her work and family life.

Our Cancer Stories
OutcomeCare Ongoing
Margaret, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Margaret's Patient Story

Patient Info: Margaret | Stage II

Margaret chose mastectomy and hormone therapy and reported no treatment side effects while remaining optimistic about recovery.

Our Cancer Stories
OutcomeNot reported
Rose, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Rose's Patient Story

Patient Info: Rose | Stage II

Rose remains on radiotherapy, hormone therapy and targeted therapy while continuing to live with concerns about recurrence and metastasis.

Our Cancer Stories
OutcomeCare Ongoing
Angelina, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Angelina's Patient Story

Patient Info: Angelina, Female, 50s | Stage II

As of 2023, Angelina was undergoing Stage II breast cancer treatment with DIEP mastectomy, chemotherapy, radiation therapy, and hormone therapy, and was focused on recuperation and future goals.

Our Cancer Stories
OutcomeCare Ongoing